WHO recommendations for misoprostol use for obstetric and gynecologic indications

Jennifer Tang, Nathalie Kapp, Monica Dragoman, Joao Paulo De Souza

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Background Misoprostol, a prostaglandin E1 analog, stimulates uterine contractility and cervical ripening. A number of randomized trials and systematic reviews have evaluated its use in obstetric and gynecologic conditions. Misoprostol is inexpensive, stable at room temperature, and available in more than 80 countries, making it particularly useful in resource-poor settings. WHO recognizes the crucial role of misoprostol in reproductive health and has incorporated recommendations for its use into 4 reproductive health guidelines focused on induction of labor, prevention and treatment of postpartum hemorrhage, and management of spontaneous and induced abortion. Methods and results All guidelines were prepared in accordance with the WHO Handbook for Guideline Development. The process included: identification of priority questions and critical outcomes; retrieval of evidence; assessment and synthesis of evidence; formulation of recommendations; and planning for dissemination, implementation, impact evaluation, and updating. The present report summarizes recommendations for misoprostol use in line with each guideline. Conclusion The present comprehensive reference document was designed to enable clinicians and policy makers to quickly access and compare recommendations for the use of misoprostol in various reproductive health settings.

Original languageEnglish (US)
Pages (from-to)186-189
Number of pages4
JournalInternational Journal of Gynecology and Obstetrics
Volume121
Issue number2
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

Misoprostol
Obstetrics
Reproductive Health
Guidelines
Cervical Ripening
Induced Labor
Synthetic Prostaglandins
Postpartum Hemorrhage
Induced Abortion
Alprostadil
Spontaneous Abortion
Administrative Personnel
Temperature

Keywords

  • Abortion
  • Guidelines
  • Labor induction
  • Misoprostol
  • Postpartum hemorrhage
  • Recommendations

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

WHO recommendations for misoprostol use for obstetric and gynecologic indications. / Tang, Jennifer; Kapp, Nathalie; Dragoman, Monica; De Souza, Joao Paulo.

In: International Journal of Gynecology and Obstetrics, Vol. 121, No. 2, 05.2013, p. 186-189.

Research output: Contribution to journalArticle

Tang, Jennifer ; Kapp, Nathalie ; Dragoman, Monica ; De Souza, Joao Paulo. / WHO recommendations for misoprostol use for obstetric and gynecologic indications. In: International Journal of Gynecology and Obstetrics. 2013 ; Vol. 121, No. 2. pp. 186-189.
@article{60fae50a80594d58b863429b75fc8966,
title = "WHO recommendations for misoprostol use for obstetric and gynecologic indications",
abstract = "Background Misoprostol, a prostaglandin E1 analog, stimulates uterine contractility and cervical ripening. A number of randomized trials and systematic reviews have evaluated its use in obstetric and gynecologic conditions. Misoprostol is inexpensive, stable at room temperature, and available in more than 80 countries, making it particularly useful in resource-poor settings. WHO recognizes the crucial role of misoprostol in reproductive health and has incorporated recommendations for its use into 4 reproductive health guidelines focused on induction of labor, prevention and treatment of postpartum hemorrhage, and management of spontaneous and induced abortion. Methods and results All guidelines were prepared in accordance with the WHO Handbook for Guideline Development. The process included: identification of priority questions and critical outcomes; retrieval of evidence; assessment and synthesis of evidence; formulation of recommendations; and planning for dissemination, implementation, impact evaluation, and updating. The present report summarizes recommendations for misoprostol use in line with each guideline. Conclusion The present comprehensive reference document was designed to enable clinicians and policy makers to quickly access and compare recommendations for the use of misoprostol in various reproductive health settings.",
keywords = "Abortion, Guidelines, Labor induction, Misoprostol, Postpartum hemorrhage, Recommendations",
author = "Jennifer Tang and Nathalie Kapp and Monica Dragoman and {De Souza}, {Joao Paulo}",
year = "2013",
month = "5",
doi = "10.1016/j.ijgo.2012.12.009",
language = "English (US)",
volume = "121",
pages = "186--189",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - WHO recommendations for misoprostol use for obstetric and gynecologic indications

AU - Tang, Jennifer

AU - Kapp, Nathalie

AU - Dragoman, Monica

AU - De Souza, Joao Paulo

PY - 2013/5

Y1 - 2013/5

N2 - Background Misoprostol, a prostaglandin E1 analog, stimulates uterine contractility and cervical ripening. A number of randomized trials and systematic reviews have evaluated its use in obstetric and gynecologic conditions. Misoprostol is inexpensive, stable at room temperature, and available in more than 80 countries, making it particularly useful in resource-poor settings. WHO recognizes the crucial role of misoprostol in reproductive health and has incorporated recommendations for its use into 4 reproductive health guidelines focused on induction of labor, prevention and treatment of postpartum hemorrhage, and management of spontaneous and induced abortion. Methods and results All guidelines were prepared in accordance with the WHO Handbook for Guideline Development. The process included: identification of priority questions and critical outcomes; retrieval of evidence; assessment and synthesis of evidence; formulation of recommendations; and planning for dissemination, implementation, impact evaluation, and updating. The present report summarizes recommendations for misoprostol use in line with each guideline. Conclusion The present comprehensive reference document was designed to enable clinicians and policy makers to quickly access and compare recommendations for the use of misoprostol in various reproductive health settings.

AB - Background Misoprostol, a prostaglandin E1 analog, stimulates uterine contractility and cervical ripening. A number of randomized trials and systematic reviews have evaluated its use in obstetric and gynecologic conditions. Misoprostol is inexpensive, stable at room temperature, and available in more than 80 countries, making it particularly useful in resource-poor settings. WHO recognizes the crucial role of misoprostol in reproductive health and has incorporated recommendations for its use into 4 reproductive health guidelines focused on induction of labor, prevention and treatment of postpartum hemorrhage, and management of spontaneous and induced abortion. Methods and results All guidelines were prepared in accordance with the WHO Handbook for Guideline Development. The process included: identification of priority questions and critical outcomes; retrieval of evidence; assessment and synthesis of evidence; formulation of recommendations; and planning for dissemination, implementation, impact evaluation, and updating. The present report summarizes recommendations for misoprostol use in line with each guideline. Conclusion The present comprehensive reference document was designed to enable clinicians and policy makers to quickly access and compare recommendations for the use of misoprostol in various reproductive health settings.

KW - Abortion

KW - Guidelines

KW - Labor induction

KW - Misoprostol

KW - Postpartum hemorrhage

KW - Recommendations

UR - http://www.scopus.com/inward/record.url?scp=84876046269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876046269&partnerID=8YFLogxK

U2 - 10.1016/j.ijgo.2012.12.009

DO - 10.1016/j.ijgo.2012.12.009

M3 - Article

C2 - 23433680

AN - SCOPUS:84876046269

VL - 121

SP - 186

EP - 189

JO - International Journal of Gynecology and Obstetrics

JF - International Journal of Gynecology and Obstetrics

SN - 0020-7292

IS - 2

ER -